Design, synthesis, and in-vitro evaluation of β-(Thiosemicarbazide/Thiosemicarbazone)-Sulfides targeting Klebsiella pneumoniae: exploring binding interactions with topoisomerase IV and KPC-2 carbapenemase via molecular docking